Weekly Recap | Cocrystal Pharma -2.42%, late-week volume reboundWeekly Review·Sep 19, 2026 at 05:57 AMCOCP+0.44%
21:01 ETKaneka Intends to Appeal Invalidity Decision in Lawsuit Against CoCrystalprnewswire·Sep 9, 2026 at 01:05 AMCOCP+0.44%4118
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors | COCP Stock NewsStockTitan·Aug 17, 2026 at 07:17 AMCOCP+0.44%
Cocrystal Pharma Q2 FY26 net loss widens to $3.16 million; R&D expense climbs to $2.14 millionPUBT·Aug 13, 2026 at 11:31 AMCOCP+0.44%
OPKO Health, Inc. Discloses Investment in Cocrystal Pharma with 29.6% StakeTradingView·Aug 7, 2026 at 11:56 PMCOCP+0.44%OPK-0.64%
Cocrystal Pharma director Phillip Frost reports $9,816 common share purchasePUBT·Aug 6, 2026 at 09:26 PMCOCP+0.44%
The 2026 Market Fringes: AI Grifters, Reverse Splits, and A Few Real BusinessesGlobal Report·Aug 5, 2026 at 09:13 AMPI+3.12%EXPE+0.89%
From Crypto Pivots to AI Contracts: Niche Equities Reengineer Balance Sheets in 2026Global Report·Aug 4, 2026 at 09:17 AMSHPH+5.57%VSEE0.00%
Cocrystal Pharma sells 5,474,053 shares to OPKO in USD 5 million private placementPUBT·Aug 3, 2026 at 11:01 AMOPK-0.64%
Cocrystal Pharma Shareholders Approve Governance and Oversight MeasuresTip Ranks·Jul 17, 2026 at 12:28 PMCOCP+0.44%
